Reata Pharmaceuticals, Inc. Stock
Equities
RETA
US75615P1030
Biotechnology & Medical Research
Latest transcript on Reata Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director of Finance/CFO | 60 | 23-09-25 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director/Board Member | - | 23-09-25 | |
Michael Dambach
BRD | Director/Board Member | - | 23-09-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 773 M€ | -.--% | - | |
0.04% | 509 M€ | -.--% |
1st Jan change | Capi. | |
---|---|---|
-1.32% | 105B | |
+3.72% | 97.5B | |
+1.86% | 22.19B | |
-16.59% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.28% | 14.52B | |
+5.26% | 14.09B | |
+29.63% | 10.99B |